Rising Creatinine in an Adolescent Transplant Recipient
A 15-year-old boy with a deceased-donor kidney transplant 18 months ago presents with 2 days of fever and graft tenderness. Baseline creatinine is 0.95 mg/dL; today it is 2.1 mg/dL. Tacrolimus trough is 2.8 ng/mL, and he admits missing doses for 10 days because of acne. BK viral load is 18,000 copies/mL. The donor was CMV seropositive, the recipient seronegative, and he is on valganciclovir. Urinalysis shows 2+ protein and 5–10 white cells/hpf but no red-cell casts. Ultrasound shows no hydronephrosis and normal resistive indices. BP is 148/92 mmHg.
1. Construct a prioritized differential for his acute graft dysfunction and state which tests and actions should occur immediately.
Read the worked answer
Differential. Acute T-cell–mediated rejection is high on the list because of nonadherence and a subtherapeutic tacrolimus level. BK virus nephropathy can also raise creatinine with minimal urinalysis findings and is favored by BK viremia. CMV disease is possible given donor-positive/recipient-negative status, although valganciclovir reduces risk. Other considerations include pyelonephritis, drug toxicity, obstruction (ultrasound normal), and recurrent glomerular disease.
Immediate tests. Check creatinine trend, tacrolimus trough, donor-specific antibodies, CMV PCR, quantitative BK PCR, urinalysis with culture, and blood cultures. Review the medication history and adherence. Renal ultrasound is already reassuring against obstruction. Do not simply increase immunosuppression before infection is assessed, because intensifying therapy in BK nephropathy or CMV can be harmful.
Biopsy. Arrange kidney biopsy with immunofluorescence and BK staining (SV40) if safe. Biopsy distinguishes rejection from BK nephropathy and guides opposite treatments.
2. How do you interpret the low tacrolimus level and BK viremia when deciding whether to reduce or increase immunosuppression?
Read the worked answer
Interpretation. The low tacrolimus level is not therapeutic; it reflects missed doses and creates a high risk of rejection. The BK viral load of 18,000 copies/mL is significant but not diagnostic of nephropathy; BK viremia can occur without graft invasion. Fever and graft tenderness are nonspecific.
Decision. If biopsy shows acute rejection, treat with pulse steroids and restore baseline immunosuppression, checking donor-specific antibodies. If biopsy shows BK nephropathy, reduce immunosuppression and monitor viral load; do not pulse steroids. If both are present, the biopsy grade and BK stain guide a balanced approach. Empiric high-dose steroids without a biopsy could worsen BK nephropathy or infection.
Practical point. Do not reduce immunosuppression solely because of a detectable BK viral load when the patient is nonadherent and has graft tenderness; the low tacrolimus level is the more immediate threat. Conversely, do not ignore BK.
3. Outline a long-term adherence and monitoring plan for this adolescent.
Read the worked answer
Adherence. Use a simplified regimen, pillbox, phone reminders, and directly observed therapy if needed. Identify the reason for stopping tacrolimus-acne-and treat it without stopping the drug. Involve the family and a transplant pharmacist. Screen for depression and substance use, and transition care to an adult program gradually.
Monitoring. Check creatinine, tacrolimus trough, BK PCR, CMV PCR, and donor-specific antibodies at scheduled intervals and after any dysfunction. Monitor blood pressure and proteinuria. Vaccinate before transplant and update afterwards, avoiding live vaccines on high immunosuppression.
Counseling. Explain that missed doses can cause silent rejection and graft loss. Discuss the need for sun protection and infection precautions. If BK nephropathy is confirmed, coordinate reduction of immunosuppression with close viral-load monitoring. Long-term graft survival depends on both adherence and avoidance of over-immunosuppression.